主要股东
注:以下部分股东代表特定权益共同体,直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | David M. Mott | 否 | 8035.03万 | 14.22% | 新增 | 新增 | -- |
| 2 | Matrix Capital Management Master Fund L.P | 是 | 7328.11万 | 12.97% | 新增 | 新增 | -- |
| 3 | Capital World Investors | 是 | 4075.62万 | 7.22% | 新增 | 新增 | -- |
| 4 | Peter Thompson | 否 | 3094.97万 | 5.48% | 新增 | 新增 | -- |
| 5 | Nicholas Cross | 是 | 2904.28万 | 5.14% | 新增 | 新增 | -- |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2025-09-02 | Wood Gavin |
|
-- | 0.0099 | 是 | Chief Financial Officer |
| 2025-08-28 | Bertrand William C JR |
|
98.64 | 0.01 | 是 | Chief Operating Officer |
| 2025-01-17 | Bertrand William C JR |
|
0.75 | 0.58 | 是 | Chief Operating Officer |
| 2025-01-17 | Rawcliffe Adrian |
|
4.43 | 0.58 | 是 | Chief Executive Officer |
| 2025-01-17 | Lunger John |
|
0.75 | 0.58 | 是 | Chief Patient Supply Officer |
| 2025-01-17 | Norry Elliot |
|
0.75 | 0.58 | 是 | Chief Medical Officer |
| 2025-01-15 | Piccina Cintia |
|
1.84 | 0.57 | 是 | Chief Commercial Officer |
| 2025-01-13 | Lunger John |
|
0.58 | 0.59 | 是 | Chief Patient Supply Officer |
| 2025-01-13 | Lunger John |
|
0.76 | 0.59 | 是 | Chief Patient Supply Officer |
| 2025-01-13 | Lunger John |
|
1.38 | 0.57 | 是 | Chief Patient Supply Officer |
| 2025-01-13 | Bertrand William C JR |
|
0.58 | 0.59 | 是 | Chief Operating Officer |
| 2025-01-13 | Bertrand William C JR |
|
0.76 | 0.59 | 是 | Chief Operating Officer |
| 2025-01-13 | Bertrand William C JR |
|
1.38 | 0.57 | 是 | Chief Operating Officer |
| 2025-01-13 | Norry Elliot |
|
0.58 | 0.59 | 是 | Chief Medical Officer |
| 2025-01-13 | Norry Elliot |
|
1.15 | 0.59 | 是 | Chief Medical Officer |
| 2025-01-13 | Norry Elliot |
|
1.38 | 0.57 | 是 | Chief Medical Officer |
| 2025-01-13 | Rawcliffe Adrian |
|
1.78 | 0.59 | 是 | Chief Executive Officer |
| 2025-01-13 | Rawcliffe Adrian |
|
2.57 | 0.59 | 是 | Chief Executive Officer |
| 2025-01-13 | Rawcliffe Adrian |
|
4.16 | 0.57 | 是 | Chief Executive Officer |
| 2024-06-18 | Piccina Cintia |
|
3.83 | 0.93 | 是 | Chief Commercial Officer |
| 2024-01-16 | Lunger John |
|
0.78 | 0.67 | 是 | Chief Patient Supply Officer |
| 2024-01-16 | Lunger John |
|
1.90 | 0.67 | 是 | Chief Patient Supply Officer |
| 2024-01-16 | Norry Elliot |
|
0.34 | 0.79 | 是 | Chief Medical Officer |
| 2024-01-16 | Norry Elliot |
|
0.78 | 0.67 | 是 | Chief Medical Officer |
| 2024-01-16 | Norry Elliot |
|
1.93 | 0.67 | 是 | Chief Medical Officer |
| 2024-01-16 | Bertrand William C JR |
|
0.70 | 0.79 | 是 | Chief Operating Officer |
| 2024-01-16 | Bertrand William C JR |
|
0.78 | 0.67 | 是 | Chief Operating Officer |
| 2024-01-16 | Bertrand William C JR |
|
2.02 | 0.67 | 是 | Chief Operating Officer |
| 2024-01-16 | Rawcliffe Adrian |
|
1.41 | 0.79 | 是 | Chief Executive Officer |
| 2024-01-16 | Rawcliffe Adrian |
|
4.48 | 0.67 | 是 | Chief Executive Officer |
| 2024-01-16 | Lunger John |
|
0.70 | 0.79 | 是 | Chief Patient Supply Officer |
| 2024-01-11 | Norry Elliot |
|
0.61 | 0.84 | 是 | Chief Medical Officer |
| 2024-01-11 | Norry Elliot |
|
1.18 | 0.85 | 是 | Chief Medical Officer |
| 2024-01-11 | Rawcliffe Adrian |
|
1.84 | 0.84 | 是 | Chief Executive Officer |
| 2024-01-11 | Rawcliffe Adrian |
|
2.64 | 0.85 | 是 | Chief Executive Officer |
| 2024-01-11 | Bertrand William C JR |
|
0.61 | 0.84 | 是 | Chief Operating Officer |
| 2024-01-11 | Bertrand William C JR |
|
0.79 | 0.85 | 是 | Chief Operating Officer |
| 2024-01-11 | Lunger John |
|
0.61 | 0.84 | 是 | Chief Patient Supply Officer |
| 2024-01-11 | Lunger John |
|
0.79 | 0.85 | 是 | Chief Patient Supply Officer |